GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Other Operating Expense

Noile-Immune Biotech (TSE:4893) Other Operating Expense : 円-0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Other Operating Expense?

Noile-Immune Biotech's Other Operating Expense for the three months ended in Mar. 2024 was 円0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円-0.0 Mil.

Noile-Immune Biotech's quarterly Other Operating Expense stayed the same from Sep. 2023 (円-0.0 Mil) to Dec. 2023 (円-0.0 Mil) but then increased from Dec. 2023 (円-0.0 Mil) to Mar. 2024 (円0.0 Mil).

Noile-Immune Biotech's annual Other Operating Expense increased from Dec. 2021 (円-0.0 Mil) to Dec. 2022 (円0.0 Mil) but then declined from Dec. 2022 (円0.0 Mil) to Dec. 2023 (円-0.0 Mil).

Noile-Immune Biotech Other Operating Expense Historical Data

The historical data trend for Noile-Immune Biotech's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Other Operating Expense Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Operating Expense
- - - -

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only - - - - -

Noile-Immune Biotech Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Other Operating Expense
Comparable Companies
TSE:4575 TSE:4563 TSE:4978 TSE:4579 TSE:7774 TSE:2183 TSE:7096 TSE:4894 TSE:4571 TSE:4593 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Website
https://www.noile-immune.com
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines